One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients

One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients

Dendritic cells (DCs) and cytokine-induced killer (CIK) cells play an important role in the anti-tumor immune response. In this study, we evaluated the clinical effectiveness of DC/CIK-CD24 immunotherapies to primary hepatocellular carcinoma patients who received radical resection. 36 resected prima...

Full description

Bibliographic Details
Main Authors: Kaiyue Xu, Zhengjie Meng, Xiaoxin Mu, Beicheng Sun, Yi Chai
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Oncology
Subjects:
dendritic cells
cytokine-induced killer cells
primary hepatocellular carcinoma
immunotherapy
CD24
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.581270/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.581270/full

Similar Items